title: Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc.
abstract: Hantaviruses can cause hantavirus pulmonary syndrome or hemorrhagic fever with renal syndrome in humans. To enter cells, hantaviruses fuse their envelope membrane with host cell membranes. Previously, we have shown that the Gc envelope glycoprotein is the viral fusion protein sharing characteristics with class II fusion proteins. The ectodomain of class II fusion proteins is composed of three domains connected by a stem region to a transmembrane anchor in the viral envelope. These fusion proteins can be inhibited through exogenous fusion protein fragments spanning domain III (DIII) and the stem region. Such fragments are thought to interact with the core of the fusion protein trimer during the transition from its pre-fusion to its post-fusion conformation. Based on our previous homology model structure for Gc from Andes hantavirus (ANDV), here we predicted and generated recombinant DIII and stem peptides to test whether these fragments inhibit hantavirus membrane fusion and cell entry. Recombinant ANDV DIII was soluble, presented disulfide bridges and beta-sheet secondary structure, supporting the in silico model. Using DIII and the C-terminal part of the stem region, the infection of cells by ANDV was blocked up to 60% when fusion of ANDV occurred within the endosomal route, and up to 95% when fusion occurred with the plasma membrane. Furthermore, the fragments impaired ANDV glycoprotein-mediated cell-cell fusion, and cross-inhibited the fusion mediated by the glycoproteins from Puumala virus (PUUV). The Gc fragments interfered in ANDV cell entry by preventing membrane hemifusion and pore formation, retaining Gc in a non-resistant homotrimer stage, as described for DIII and stem peptide inhibitors of class II fusion proteins. Collectively, our results demonstrate that hantavirus Gc shares not only structural, but also mechanistic similarity with class II viral fusion proteins, and will hopefully help in developing novel therapeutic strategies against hantaviruses.
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Gonzalo P
authors.initials: GP
authors.lastname: Barriga
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Fernando
authors.initials: F
authors.lastname: Villalón-Letelier
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Chantal L
authors.initials: CL
authors.lastname: Márquez
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Eduardo A
authors.initials: EA
authors.lastname: Bignon
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Acuña
authors.affiliation: Laboratory of Structural Cell Biology, Department of Physiology, and Center for Interdisciplinary Studies of the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, Chile.
authors.forename: Breyan H
authors.initials: BH
authors.lastname: Ross
authors.affiliation: Laboratorio de Biología Estructural y Molecular, Facultad de Ciencias, Universidad de Chile, Santiago, Chile.
authors.forename: Octavio
authors.initials: O
authors.lastname: Monasterio
authors.affiliation: Laboratory of Structural Cell Biology, Department of Physiology, and Center for Interdisciplinary Studies of the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, Chile.
authors.forename: Gonzalo A
authors.initials: GA
authors.lastname: Mardones
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Simon E
authors.initials: SE
authors.lastname: Vidal
authors.affiliation: Molecular Virology Laboratory, Fundación Ciencia & Vida, Santiago, Chile.
authors.forename: Nicole D
authors.initials: ND
authors.lastname: Tischler
mesh_terms: D006023:Glycoproteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D006476:Orthohantavirus / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D018778:Hantavirus Infections / Q000821:virology*; D006801:Humans; D010455:Peptides / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000072417:Protein Domains; D014759:Viral Envelope Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D014760:Viral Fusion Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D053586:Virus Internalization
chemical_list: D006023:Glycoproteins; D010455:Peptides; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins